Dopamine News and Research

Latest Dopamine News and Research

New laboratory model replicates early phase of Parkinson's before onset of motor symptoms

They're two of the biggest mysteries in Parkinson's disease research--where does the disease start? And how can it be stopped early in the process? Now, a new laboratory model of Parkinson's is giving scientists an inside look at what happens in the brain years before motor symptoms appear.

9 Aug 2016

Activation of specific neural circuit can inhibit binge-like eating behavior in mice

While binge eating affects about 10 percent of adults in the United States, the neurobiological basis of the disease is unclear.

8 Aug 2016

Scientists make major advance in understanding how stem cells become specialized

Scientists at Sanford Burnham Prebys Medical Discovery Institute have made a major advance in understanding how the cells of an organism, which all contain the same genetic information, come to be so diverse.

5 Aug 2016

Scientists develop interactive model to fast-track research and treatment of schizophrenia

It's called mental imbalance for a reason. Sanity hangs, in part, in the gentle balance of chemicals strung together within regions of the brain in an intricate matrix.

4 Aug 2016

UTA researchers find how changing estrogen levels make women more vulnerable to cocaine addiction

Researchers at The University of Texas at Arlington are studying how fluctuating estrogen levels make females increasingly sensitive to the rewarding effects of cocaine and ultimately, vulnerable to cocaine addiction.

2 Aug 2016

Scientists use animal model to gain better understanding of cocaine addiction

Scientists at Wake Forest Baptist Medical Center are one step closer to understanding what causes cocaine to be so addictive. The research findings are published in the current issue of the Journal of Neuroscience.

2 Aug 2016

Overcoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza

Many gene mutations that cause neurological disorders have been identified. For example, in a rare neurological disorder such as Huntington’s disease, an autosomal dominant mutation through expansion of CAG (cytosine-adenine-guanine) triplet repeats in the gene coding for the Huntingtin protein results in abnormal protein production.

1 Aug 2016

Scientists make a big leap on mini-brain research

Scientists in Singapore have made a big leap on research on the 'mini-brain'. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson's Disease and ageing-related brain diseases.

29 Jul 2016

Changes in the brain's pleasure center may decrease physical activity in postmenopausal women

As women enter menopause, their levels of physical activity decrease; for years scientists were unable to determine why.

28 Jul 2016

Smoking-related deficits in brain dopamine return to normal after quitting, study reports

A new study in Biological Psychiatry reports that smoking-related deficits in brain dopamine, a chemical implicated in reward and addiction, return to normal three months after quitting.

28 Jul 2016

New research elucidates details about architecture of synaptic transmission

For more than a century, neuroscientists have known that nerve cells talk to one another across the small gaps between them, a process known as synaptic transmission.

28 Jul 2016

Study finds risk markers for Parkinson's disease hiding in unusual spots

Clues that point toward new risk mechanisms for developing Parkinson's disease are hiding in some unusual spots, according to a study published today in Scientific Reports

28 Jul 2016

Study sheds light on neuronal circuits during risky behavior

New research sheds light on what's going on inside our heads as we decide whether to take a risk or play it safe. Scientists at Washington University School of Medicine in St. Louis located a region of the brain involved in decisions made under conditions of uncertainty, and identified some of the cells involved in the decision-making process.

27 Jul 2016

Scientists receive $2.4 million grant to advance stem cell therapy for Parkinson's disease

Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.

22 Jul 2016

Study examines link between craving and glutamate levels in the brain of patients with AUDs

Craving consists of cognitive, emotional, and behavioral elements related to a desire to drink alcohol, and can be experienced during intoxication, withdrawal, and/or prior to relapse.

21 Jul 2016

Researchers discover novel neuroprotection strategies to slow progression of Parkinson's disease

Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.

20 Jul 2016

Study compares aripiprazole and quetiapine for treatment of schizophrenia

Schizophrenia is a common cause of incapacity and is ranked as the third-most-disabling illness subsequent to dementia and quadriplegia.

15 Jul 2016

Scientists reveal how manipulating novel target in the brain could lead to new therapies for depression

Northwestern Medicine scientists have shown how manipulating a novel target in the brain using gene therapy could lead to new treatments for depression.

12 Jul 2016

Neuroscientists identify two distinct populations of dopamine neurons involved in movement, reward

Two Northwestern University neuroscientists have identified the neurochemical signal likely missing in Parkinson's disease by being the first to discover two distinctly different kinds of neurons that deliver dopamine to an important brain region responsible for both movement and learning/reward behavior.

12 Jul 2016

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson's disease or dementia with Lewy bodies.

12 Jul 2016

Dopamine News and Research

Latest Dopamine News and Research

New laboratory model replicates early phase of Parkinson's before onset of motor symptoms

Activation of specific neural circuit can inhibit binge-like eating behavior in mice

Scientists make major advance in understanding how stem cells become specialized

Scientists develop interactive model to fast-track research and treatment of schizophrenia

UTA researchers find how changing estrogen levels make women more vulnerable to cocaine addiction

Scientists use animal model to gain better understanding of cocaine addiction

Overcoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza

Scientists make a big leap on mini-brain research

Changes in the brain's pleasure center may decrease physical activity in postmenopausal women

Smoking-related deficits in brain dopamine return to normal after quitting, study reports

New research elucidates details about architecture of synaptic transmission

Study finds risk markers for Parkinson's disease hiding in unusual spots

Study sheds light on neuronal circuits during risky behavior

Scientists receive $2.4 million grant to advance stem cell therapy for Parkinson's disease

Study examines link between craving and glutamate levels in the brain of patients with AUDs

Researchers discover novel neuroprotection strategies to slow progression of Parkinson's disease

Study compares aripiprazole and quetiapine for treatment of schizophrenia

Scientists reveal how manipulating novel target in the brain could lead to new therapies for depression

Neuroscientists identify two distinct populations of dopamine neurons involved in movement, reward

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in